Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC
Open Access
- 26 February 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (13) , 16731-16744
Abstract
Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCCKeywords
This publication has 63 references indexed in Scilit:
- Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1–expressing myeloma cellsBlood, 2011
- Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial DynamicsDevelopmental Cell, 2011
- Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1Blood, 2010
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsJournal of Clinical Investigation, 2010
- BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonistsCell Death & Differentiation, 2009
- Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non–Small Cell Lung Tumor Xenograft ModelClinical Cancer Research, 2009
- ABT-737 Synergizes with Chemotherapy to Kill Head and Neck Squamous Cell Carcinoma Cells via a Noxa-Mediated PathwayMolecular Pharmacology, 2009
- Noxa: at the tip of the balance between life and deathOncogene, 2008
- Simple quantitative detection of mitochondrial superoxide production in live cellsBiochemical and Biophysical Research Communications, 2007
- The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralizedCancer Cell, 2006